ELV approaching significant overhead resistance

40
Elevance Health Inc. (ELV) approaching significant overhead resistance, able to absorb monthly buying pressures.

From here, (ELV) can reject and fall lower to channel support, eliciting losses of 15% - 20% over the following 2 - 3 months.

Inversely, a weekly settlement above resistance would place (ELV) into a buy-signal where gains of 15% - 20% would be expected over the following 2 - 5 months.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.